Ocuphire Pharma (OCUP) Insider Trading & Ownership → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free OCUP Stock Alerts $2.01 -0.01 (-0.50%) (As of 03/28/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ocuphire Pharma (NASDAQ:OCUP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$74,100.00Number OfInsiders Selling(Last 12 Months)0 Get OCUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Ocuphire Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OCUP Insider Buying and Selling by Quarter Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… Ocuphire Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/21/2024Joseph K SchachleCOOBuy2,000$2.05$4,100.00 3/21/2024Nirav S JhaveriCFOBuy10,000$2.10$21,000.00 3/18/2024George MagrathCEOBuy25,000$1.96$49,000.00 (Data available from 1/1/2013 forward) OCUP Insider Trading Activity - Frequently Asked Questions Who is on Ocuphire Pharma's Insider Roster? The list of insiders at Ocuphire Pharma includes George Magrath, James S J Manuso, Jay Pepose, Joseph K Schachle, Mina Sooch, and Nirav S Jhaveri. Learn more on insiders at OCUP. What percentage of Ocuphire Pharma stock is owned by insiders? 8.70% of Ocuphire Pharma stock is owned by insiders. Learn more on OCUP's insider holdings. Which Ocuphire Pharma insiders have been buying company stock? The following insiders have purchased OCUP shares in the last 24 months: George Magrath ($49,000.00), James S J Manuso ($9,950.00), Joseph K Schachle ($4,100.00), Mina Sooch ($25,875.00), and Nirav S Jhaveri ($21,000.00). How much insider buying is happening at Ocuphire Pharma? Insiders have purchased a total of 54,500 OCUP shares in the last 24 months for a total of $109,925.00 bought. More Insider Trading Tools from MarketBeat Related Companies: Checkpoint Therapeutics Insider Selling Gain Therapeutics Insider Selling Eyenovia Insider Selling NRx Pharmaceuticals Insider Selling Lexaria Bioscience Insider Selling Unicycive Therapeutics Insider Selling Eledon Pharmaceuticals Insider Selling SCYNEXIS Insider Selling Nabriva Therapeutics Insider Selling Bolt Biotherapeutics Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:OCUP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.